Hansoh Pharmaceutical Group Company Limited
3692.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$191.23B
Close$
Share Statistics
| Market cap | $191.23 Billion |
|---|---|
| Enterprise Value | $190.91 Billion |
| Dividend Yield | $0.43 (1.54%) |
| Earnings per Share | $0.93 |
| Beta | 0.56 |
| Outstanding Shares | 6,056,679,000 |
Return
| Return on Equity | 30.35% |
|---|---|
| Return on Assets | 24.59% |
| Return on Invested Capital | 27.27% |
Valuation & Multiples
| P/E Ratio | 24.41 |
|---|---|
| PEG | 68.14 |
| Price to Sales | 7.89 |
| Price to Book Ratio | 5.26 |
| Enterprise Value to Revenue | 6.56 |
| Enterprise Value to EBIT | 18.37 |
| Enterprise Value to Net Income | 16 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
$0.56
Average shareholder expectationRevenue Estimate
$9.52 B
Average shareholder expectationNext Earnings Call
Expected Date
March 30, 2027
EPS Estimate
$0.57
Average shareholder expectationRevenue Estimate
$10.16 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Hansoh Pharmaceutical Group Company Limited
9,643 employees
CEO: Hui Juan Zhong Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therap...